# PREVENTion of Clot in Orthopaedic Trauma

> **NCT02984384** · PHASE3 · COMPLETED · sponsor: **Major Extremity Trauma Research Consortium** · enrollment: 12424 (actual)

## Conditions studied

- Blood Clot
- Trauma

## Interventions

- **DRUG:** Acetylsalicylic acid
- **DRUG:** Low Molecular Weight Heparin (LMWH)

## Key facts

- **NCT ID:** NCT02984384
- **Lead sponsor:** Major Extremity Trauma Research Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2022-02-18
- **Final completion:** 2022-02-18
- **Target enrollment:** 12424 (ACTUAL)
- **Last updated:** 2024-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02984384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02984384, "PREVENTion of Clot in Orthopaedic Trauma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02984384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*